Intravitreal triamcinolone for intraocular inflammation and associated macular edema

Steven M Couch, Sophie J BakriMayo Clinic Department of Ophthalmology, Mayo Clinic, Rochester, MN, USAAbstract: Triamcinolone acetonide (TA) is a corticosteroid that has many uses in the treatment of ocular diseases because of its potent anti-inflammatory and anti-permeability actions. Intraocular i...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Steven M Couch, Sophie J Bakri
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/2099e6f709e24774ad57cc5b2f531d2a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2099e6f709e24774ad57cc5b2f531d2a
record_format	dspace
spelling	oai:doaj.org-article:2099e6f709e24774ad57cc5b2f531d2a2021-12-02T00:51:11ZIntravitreal triamcinolone for intraocular inflammation and associated macular edema1177-54671177-5483https://doaj.org/article/2099e6f709e24774ad57cc5b2f531d2a2008-11-01T00:00:00Zhttp://www.dovepress.com/intravitreal-triamcinolone-for-intraocular-inflammation-and-associated-a2529https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Steven M Couch, Sophie J BakriMayo Clinic Department of Ophthalmology, Mayo Clinic, Rochester, MN, USAAbstract: Triamcinolone acetonide (TA) is a corticosteroid that has many uses in the treatment of ocular diseases because of its potent anti-inflammatory and anti-permeability actions. Intraocular inflammation broadly referred to as uveitis can result from several causes, including the immune system and after ophthalmic surgery. One of the most common reasons for vision loss with uveitis is macular edema. TA has been used for many years as an intravitreal injection for the treatment of ocular diseases. Several case control studies have been reported showing the efficacy of TA in the treatment of intraocular inflammation and associated macular edema caused by Behcet&rsquo;s disease, Vogt-Koyanagi-Harada syndrome, sympathetic ophthalmia and white dot syndromes. It has also been shown efficacious in cases of pars planitis and idiopathic posterior uveitis. Some authors have reported its use in postoperative cystoid macular edema. Many of the studies on the use of TA in controlling intraocular inflammation and concomitant macular edema showed its effect to be transient in many patients requiring reinjection. Complications can arise from intravitreal injection of TA including elevated intraocular pressure and cataract. Rarely, it can be associated with infectious and non-infectious endophthalmitis. TA may be useful as an adjuvant in the treatment of uveitis and its associated macular edema, especially in patients resistant or intolerant to standard treatment.Keywords: triamcinolone acetonide, Behcet&rsquo;s disease, sympathetic ophthalmia, Vogt-Koyanagi-Harada syndrome, white dot syndromes, uveitis, cataract surgery, macular edema, endophthalmitis Steven M CouchSophie J BakriDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2009, Iss default, Pp 41-47 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Steven M Couch Sophie J Bakri Intravitreal triamcinolone for intraocular inflammation and associated macular edema
description	Steven M Couch, Sophie J BakriMayo Clinic Department of Ophthalmology, Mayo Clinic, Rochester, MN, USAAbstract: Triamcinolone acetonide (TA) is a corticosteroid that has many uses in the treatment of ocular diseases because of its potent anti-inflammatory and anti-permeability actions. Intraocular inflammation broadly referred to as uveitis can result from several causes, including the immune system and after ophthalmic surgery. One of the most common reasons for vision loss with uveitis is macular edema. TA has been used for many years as an intravitreal injection for the treatment of ocular diseases. Several case control studies have been reported showing the efficacy of TA in the treatment of intraocular inflammation and associated macular edema caused by Behcet&rsquo;s disease, Vogt-Koyanagi-Harada syndrome, sympathetic ophthalmia and white dot syndromes. It has also been shown efficacious in cases of pars planitis and idiopathic posterior uveitis. Some authors have reported its use in postoperative cystoid macular edema. Many of the studies on the use of TA in controlling intraocular inflammation and concomitant macular edema showed its effect to be transient in many patients requiring reinjection. Complications can arise from intravitreal injection of TA including elevated intraocular pressure and cataract. Rarely, it can be associated with infectious and non-infectious endophthalmitis. TA may be useful as an adjuvant in the treatment of uveitis and its associated macular edema, especially in patients resistant or intolerant to standard treatment.Keywords: triamcinolone acetonide, Behcet&rsquo;s disease, sympathetic ophthalmia, Vogt-Koyanagi-Harada syndrome, white dot syndromes, uveitis, cataract surgery, macular edema, endophthalmitis
format	article
author	Steven M Couch Sophie J Bakri
author_facet	Steven M Couch Sophie J Bakri
author_sort	Steven M Couch
title	Intravitreal triamcinolone for intraocular inflammation and associated macular edema
title_short	Intravitreal triamcinolone for intraocular inflammation and associated macular edema
title_full	Intravitreal triamcinolone for intraocular inflammation and associated macular edema
title_fullStr	Intravitreal triamcinolone for intraocular inflammation and associated macular edema
title_full_unstemmed	Intravitreal triamcinolone for intraocular inflammation and associated macular edema
title_sort	intravitreal triamcinolone for intraocular inflammation and associated macular edema
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/2099e6f709e24774ad57cc5b2f531d2a
work_keys_str_mv	AT stevenmcouch intravitrealtriamcinoloneforintraocularinflammationandassociatedmacularedema AT sophiejbakri intravitrealtriamcinoloneforintraocularinflammationandassociatedmacularedema
_version_	1718403424552222720

Intravitreal triamcinolone for intraocular inflammation and associated macular edema

Ejemplares similares